SCHEMBL19106199

SCHEMBL19106199

c1ccc(-c2nc(-c3ccc(-c4nc(-c5cccnc5)nc(-c5cc6ccccc6c6ccccc56)n4)cc3)nc3c2sc2ccccc23)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP11B1 P15538 4/20 0.48
▸ CYP1A2 P05177 3/20 0.38
▸ CYP3A4 P08684 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ CLK4 Q9HAZ1 3/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ CYP2D6 P10635 2/20 0.38
▸ CYP2C9 P11712 2/20 0.38
▸ TSHR P16473 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ GLA P06280 1/20 0.38
▸ GPR84 Q9NQS5 1/20 0.38
▸ GBA1 P04062 1/20 0.37
▸ CYP11B2 P19099 3/20 0.36
▸ LIMK1 P53667 1/20 0.36
▸ CYP2C19 P33261 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ PIM1 P11309 1/20 0.35
▸ PIM2 Q9P1W9 1/20 0.35
▸ MAPT P10636 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19106290 0.94 CYP11B1 (0.46) CYP11B1CYP1A2CYP3A4KMT2ACLK4
SCHEMBL19106205 0.92 MEN1 (0.39) CYP11B1CYP1A2CYP3A4KMT2AALDH1A1
SCHEMBL16581296 0.88 CYP11B1 (0.49) CYP11B1CYP1A2CYP3A4KMT2ACLK4
SCHEMBL19106303 0.88 CYP11B1 (0.51) CYP11B1CYP1A2CYP3A4KMT2ACLK4
SCHEMBL19106253 0.88 CYP11B1 (0.51) CYP11B1CYP1A2CYP3A4KMT2ACLK4
SCHEMBL16581220 0.86 CYP11B1 (0.52) CYP11B1KMT2AALDH1A1GPR84GBA1
SCHEMBL19106222 0.85 CYP19A1 (0.44) CYP1A2CYP3A4KMT2ACLK4ALDH1A1
SCHEMBL19106274 0.85 CYP11B1 (0.47) CYP11B1CYP1A2CYP3A4KMT2ACLK4
SCHEMBL19106353 0.84 CYP11B1 (0.37) CYP11B1KMT2AALDH1A1MEN1LIMK1
SCHEMBL19106319 0.83 ATM (0.41) CYP11B1CYP1A2CYP3A4KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same DUK SAN NEOLUX CO., LTD (KR) 2020-08-04 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME NFE2L2, ESR1, VDAC2 CYP11B1 1948/4885CYP1A2 1060/4885CYP3A4 681/4885
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same NFE2L2, ESR1, VDAC2 CYP11B1 1948/4885CYP1A2 1060/4885CYP3A4 681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback